Results 11 to 20 of about 167,102 (249)

Prognostic value of ascites in patients with liver cirrhosis undergoing cardiac surgery

open access: yesJournal of Cardiothoracic Surgery, 2023
Introduction Mild or moderate liver cirrhosis increases the risk of complications after cardiac surgery. Ascites is the most common complication associated with liver cirrhosis.
Amila Cizmic   +5 more
doaj   +1 more source

Ascites re-compensation in HBV-related first decompensated cirrhosis after anti-viral therapy

open access: yesFrontiers in Cellular and Infection Microbiology, 2023
Effective antiviral therapy can significantly improve the long-term prognosis of HBV-related decompensated patients, and re-compensation may be achieved in part of the patients. To explore the re-compensation of ascites after HBV suppression and the risk
Mingyu Li   +7 more
doaj   +1 more source

Current management of refractory ascites in patients with cirrhosis

open access: yesJournal of International Medical Research, 2018
Liver cirrhosis is a health problem worldwide, and ascites is its principal symptom. Refractory ascites is intractable and occurs in 5%–10% of all patients with ascites due to cirrhosis.
Ruihong Zhao   +5 more
doaj   +1 more source

DAXX promotes ovarian cancer ascites cell proliferation and migration by activating the ERK signaling pathway

open access: yesJournal of Ovarian Research, 2018
Background The death-domain-associated protein (DAXX) was originally identified as a protein that binds to the transmembrane death receptor FAS and enhances both FAS-induced and transforming growth factor-β-dependent apoptosis.
Sheng-Bing Liu   +4 more
doaj   +1 more source

Case Report: Ascites Reinfusion Dialysis in Patients with Idiopathic Dialysis Ascites [PDF]

open access: yesJournal of Sharif Medical & Dental College, 2016
Idiopathic dialysis ascites is an ascites of unknown etiology in patients with end stage renal disease. Here, we describe two hemodialysis patients, who had idiopathic dialysis ascites with poor response and tolerance to ultrafiltration and intermittent ...
Roshina Anjum   +3 more
doaj  

Ascites control by TIPS is more successful in patients with a lower paracentesis frequency and is associated with improved survival

open access: yesJHEP Reports, 2019
Background & Aims: Refractory ascites is the main reason for the implantation of a transjugular intrahepatic portosystemic shunt (TIPS) in liver cirrhosis, but ascites control by TIPS fails in a relevant proportion of cases. Here, we investigated whether
Felix Piecha   +11 more
doaj   +1 more source

Role of Ambulatory Laparoscopy in Diagnosis of Ascites with Unknown Etiology

open access: yesIndonesian Journal of Obstetrics and Gynecology, 2021
Background: Ascites could be caused by many underlying diseases, mainly portal hypertension, malignancy, and heart failure. Other etiologies include tuberculosis and pancreatitis.
Herbert Situmorang   +2 more
doaj   +1 more source

Contemporary management of pain in cirrhosis: Toward precision therapy for pain

open access: yesHepatology, EarlyView., 2022
Abstract Chronic pain is highly prevalent in patients with cirrhosis and is associated with poor health‐related quality of life and poor functional status. However, there is limited guidance on appropriate pain management in this population, and pharmacologic treatment can be harmful, leading to adverse outcomes, such as gastrointestinal bleeding ...
Alexis Holman   +4 more
wiley   +1 more source

The prosurvival activity of ascites against TRAIL is associated with a shorter disease-free interval in patients with ovarian cancer

open access: yesJournal of Ovarian Research, 2010
Background The production of ascites is a common complication of ovarian cancer. Ascites constitute a unique tumor microenvironment that may affect disease progression.
Lane Denis   +3 more
doaj   +1 more source

Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness

open access: yesHepatology, EarlyView., 2022
Abstract Background and Aims Reliable noninvasive biomarkers are an unmet clinical need for the diagnosis of NASH. This study investigates the diagnostic accuracy of the circulating triggering receptor expressed on myeloid cells 2 (plasma TREM2) as a biomarker for NASH in patients with NAFLD and elevated liver stiffness.
Vineesh Indira Chandran   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy